Abstract Competition

We would like to announce that abstract submissions for The 17th Medan Cardiovascular Update 2026 have officially closed as of July 20, 2026, at 23:59 WIB. We extend our sincere gratitude to all researchers, clinicians, and participants who submitted their work through our portal at mecup2026.com.

Important Information for Submitters:

• Selection & Results Announcement: All submitted abstracts are currently undergoing evaluation by the Scientific Committee. Final selection results and the assigned presentation format (oral presentation or moderated poster) will be announced in early August 2026 via email notification to each submitter.
• Requirements Upon Acceptance: In accordance with the submission guidelines, the submitter serves as the first author and presenter, committing to present the work in-person in Medan. If your abstract is accepted, you must register for the main symposium of The 17th Medan Cardiovascular Update 2026. Failure to register will result in the withdrawal of the abstract from the scientific program. Presentations and discussions may be conducted in either English or Bahasa Indonesia.
• Finality of Submissions: Please note that no further edits or corrections to the content, author list, presenter details, or topic can be made once an abstract has been submitted.

If you have any questions or require further information regarding your submission, please feel free to contact us at : 

Important information to consider before submitting your abstract :

• All submissions must be made in English.
• All participants wishing to submit an abstract must register for the symposium.
• Abstract must be sent to our form at mecup2026.com.  Other methods of submission will not be accepted.
• The submission deadline is July 20  2026, 23.59 WIB. No late submissions will be accepted.
• Please note that the submitter must be the first author and and he/she will be the presenter of the abstract.
• Submission of an abstract constitutes a formal commitment by the submitter to present the work in-person in Medan at The 17th Medan Cardiovascular Update 2026, if acceptedAbstract submitters will receive an email confirmation after submitting their abstracts.
• Once an abstract is submitted, it is not possible to make any corrections to the content or informations (such as presenter details, topic, authors’ list etc...).
• Patient data (name, date of birth, hospital number ....) must be removed. Please pay attention in deleting such information on images or clips included in your submission.
• Use generic drugs name. The use of commercial drugs names or brands is strictly prohibited.
• Your abstract must list at least 1 author in order to be submitted. Please make sure the information given for each author is correct, as no changes will be possible after the abstract is submitted.
• There is no limit to the number of abstracts an author may submit.
• The final selection will be made by the scientific members in Early July 2026 that will determine the format of presentation for each abstract (oral presentation or moderated poster).
• Results will be announced in Early August 2026. A notification of acceptance or rejection will be emailed to each submitter. If the abstract is accepted, further instructions will be provided at the time of results announcement.
• If an abstract is accepted, the submitter must register for the main symposium of The 17th Medan Cardiovascular Update 2026. Failure to register will lead to withdrawal of the abstract from scientific programme.
• Presentation and interaction on the research or clinical case can be conducted in English or Bahasa Indonesia.
• If you have difficulties in submitting your abstracts or if you need any further information, please contact us at .

•  The 17th Medan Cardiovascular Update 2026 welcomes abstracts in two categories : original research and clinical case.
• All abstracts must be written in English.
• Use an A4 paper size, Times New Roman 12 pt for the text font and symbol for the Greek and special characters.
• Abstracts should use justify as the paragraph style (align left and right), typed in 1.5 space, and a 2.5 cm margin on all sides.
• Supported file formats are MS Word and Word Document (.doc or .docx), other file formats will not be accepted.
• The abstract should not exceed 300 words (excluding the title, authors, and affiliations).
• The title should be written in bold and not contain abbreviations.List of author(s), affiliation(s), city and country should be written immediately below the title.

• Affiliation(s), city and country should be written in italics and the first author’s name should  be underlined. 

Example:

Sophia Khairina Khaidirman MD¹ , Harris Hasan FIHA², Cut Aryfa Andra FIHA² , Hilfan Ade Putra Lubis², T. Bob Haykal²

¹ Resident of Department of Cardiology and Vascular Diseases, H. Adam Malik General Hospital/University of North Sumatera, Medan, Indonesia

² Staff of Department of Cardiology and Vascular Diseases, H. Adam Malik General Hospital/University of North Sumatera, Medan, Indonesia

• Use zero before decimal point, dot (.) for making decimal point and use lowercase p values. For example p<0.05.
• A maximum of 1 figure or table is allowed to be included in the abstract in the form of PNG, JPEG or JPG (minimal 200 dpi)
• Do not include references, credits or grant support.
• Abstract submission format.

Original Research

i. Background and Aims
ii. Methods
iii. Results
iv. Conclusions
v. Keywords (a maximum of 6 keywords may be submitted)

Clinical Case

i. Case Ilustration
ii. Discussion
iii. Conclusion
iv. Keywords (a maximum of 6 keywords may be submitted)

Sorry. This form is no longer available.